Bladder cancer typically originates in the cells that line the interior of the bladder. Because most cases are diagnosed at an early stage, bladder cancer is considered highly treatable. Risk for developing cancer is increased with smoking, age, exposure to certain chemicals, certain diabetes medications, and frequent bladder inflammations. However, bladder cancer is most common in white men. Treatments for bladder cancer include surgery, immunotherapy, chemotherapy, and radiation therapy. Superficial bladder cancer, also known as non-muscle invasive bladder cancer, is the most common type of bladder cancer and is frequently located on the surface of the interior lining of the bladder. At this stage, the cancer is confined to the lining of the bladder. Approximately 75% of individuals diagnosed with bladder cancer will receive a diagnosis of superficial bladder cancer. Superficial bladder cancer is often easily treated. Superficial bladder cancer is divided into three stages based on the progression of the cancer in this superficial stage.
Superficial Bladder Cancer Bioinformatics Tool
Laverne is a handy bioinformatics tool to help facilitate scientific exploration of related genes, diseases and pathways based on co-citations. Explore more on Superficial Bladder Cancer below!
For more information on how to use Laverne, please read the How to Guide.
We have 2981 products for the study of Superficial Bladder Cancer that can be applied to Flow Cytometry, Western Blot, Chromatin Immunoprecipitation, Immunocytochemistry/Immunofluorescence, Immunohistochemistry, Chromatin Immunoprecipitation (ChIP) from our catalog of antibodies and ELISA kits.